BioMarin Pharmaceuticals
BMRN
BMRN
316 hedge funds and large institutions have $10.7B invested in BioMarin Pharmaceuticals in 2014 Q3 according to their latest regulatory filings, with 35 funds opening new positions, 110 increasing their positions, 123 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
11% less repeat investments, than reductions
Existing positions increased: 110 | Existing positions reduced: 123
18% less funds holding in top 10
Funds holding in top 10: 11 → 9 (-2)
Holders
316
Holding in Top 10
9
Calls
$86.2M
Puts
$34M
Top Buyers
| 1 | +$243M | |
| 2 | +$97.1M | |
| 3 | +$45.8M | |
| 4 |
Jennison Associates
New York
|
+$44.6M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$42.2M |
Top Sellers
| 1 | -$89.3M | |
| 2 | -$80.6M | |
| 3 | -$51M | |
| 4 |
Millennium Management
New York
|
-$50.7M |
| 5 |
JCP
Jabre Capital Partners
Geneva,
Switzerland
|
-$48.5M |